Humana (NYSE: HUM) trades ahead of July 29 results
Humana dropped 3.6% by 1 p.m. Thursday, giving up an initial 4.1% rise at the open. The stock turned lower even as UnitedHealth Group posted strong results.
UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure
UnitedHealth Group shares climbed over 5% Thursday morning after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target. Wall Street is showing new support for the health insurer’s recovery bet.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline
UnitedHealth Group shares climbed Tuesday, last changing hands at $396.45, up $12.01—roughly a 3.1% jump. The session saw some volatility: the stock kicked off at $383.68, dipped to $382.06, before momentum took over and bulls drove it up to $397.33 toward the close.
Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play
Shares of Humana Inc. surged 11.27% on Friday, finishing at $274.96. Investors zeroed in on cost trends across the U.S. managed-care space, driving the Medicare insurer’s stock sharply higher. HUM had ended Thursday at $247.12, according to Humana’s historical prices.
Why Humana Stock’s 25% Rally Is Facing a Profit-Cut Reality Check
Humana’s stock comeback is hitting a snag. The insurer has cut its 2026 earnings forecast under U.S. accounting standards, yet investors keep betting on a Medicare Advantage turnaround that remains out of reach.
Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On
Humana Inc. topped Wall Street’s Q1 profit forecasts Wednesday. Still, shares slid over 6% premarket as the health insurer left its 2026 adjusted profit target untouched and cut its reported earnings guidance.
UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play
UnitedHealth Group Incorporated saw its shares jump roughly 4% to $369.41 early Tuesday afternoon, lifted alongside other U.S. health insurers after Centene issued another profit outlook boost. Centene surged more than 14%. Humana and CVS Health picked up gains as well, as the latest guidance stoked hopes that the sector’s medical-cost crunch could be loosening its grip.
US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally
Stocks faded into the red Tuesday afternoon, with renewed gains in oil and Treasury yields wiping out the morning’s strength. By early afternoon, the S&P 500 slipped 0.32% to 7,086.48. The Nasdaq Composite fell 0.29% to 24,334.67, and the Dow Jones Industrial Average dropped 0.27% to 49,307.73—each index had been in positive territory earlier.
UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny
UnitedHealth Group shares dropped over 4% Friday, deepening losses that had already triggered fresh talk about valuation and next week's earnings after sinking 1.6% earlier in the week. The stock changed hands at $257.04 by mid-afternoon in New York.
Humana stock jumps 6% as Medicare Advantage enrollment report puts HUM back in focus
Humana Inc jumped 6.1% Thursday, finishing the day at $186.83 after moving within a range of $177.75 to $187.44. Even with the rally, shares remain down about 41% from their 52-week peak, but are sitting roughly 10% above the 52-week low.
UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus
Shares of UnitedHealth Group jumped close to 2% Thursday, bucking a broad market downturn as investors sifted through new updates from the hard-hit U.S. managed-care space. The stock traded as high as $284.44 and as low as $275.86, settling near $284.37, up about 2%.
Humana stock slips after Medicare star ratings hit 2026 profit outlook
Humana dropped 1.9% to $177.87 by midday Wednesday, after the health insurer said it expects 2026 profit to miss analyst targets. The company blamed softer government quality scores on its Medicare Advantage plans for the outlook.
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call
UnitedHealth Group Inc dipped 0.3% to $275.70 in post-market trade Monday. The stock moved between $273.88 and $280.15 earlier in the day, with more than 10 million shares changing hands.
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next
UnitedHealth Group Incorporated ended Friday with a 3% gain, finishing at $276.65. U.S. markets remain closed Sunday, so investors are already looking ahead to what might set the tone before the open on Monday.
UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms
UnitedHealth Group Incorporated finished the regular session with a 3.4% gain, closing at $277.57. In late after-hours trading, the stock was holding up, last seen up nearly 3% at $276.65.
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus
Shares of UnitedHealth Group Incorporated dropped roughly 3% on Wednesday, slipping to a session low of $274.04. In after-hours trading, the stock was last down 2.9%, trading at $275.92.
UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus
Shares of UnitedHealth Group Incorporated dropped roughly 3% Wednesday, closing at $275.58 after hitting a low of $275.18. Meanwhile, Humana and Cigna saw gains, and CVS Health slipped slightly.
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom
UnitedHealth Group shares rose $2.82, roughly 1%, closing at $289.75 on Monday. The stock bounced back after slipping early in after-hours trading, fluctuating between $282.36 and $290.37 throughout the session.
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH
Shares of UnitedHealth Group Incorporated slipped 0.6% to $292.29 in after-hours trading Thursday. Earlier, the stock fluctuated between $289.31 and $295.94. Investors reacted to a fresh U.S. proposal aimed at tightening disclosure rules for pharmacy benefit managers, a segment where UnitedHealth’s OptumRx holds significant sway.
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters
Elevance Health shares climbed roughly 1% to $345.44 Thursday afternoon, extending a bounce in U.S. managed-care stocks following a volatile two-day stretch driven by policy news and earnings reports. UnitedHealth edged up 0.1%, Humana jumped 1.8%, and CVS Health rose 0.4%.